The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam
Open accessAbstract
As root symbionts of cycad trees, cyanobacteria of the genus Nostoc produce β-methylamino- l -alanine (BMAA), a neurotoxic nonprotein amino acid. The biomagnification of BMAA through the Guam ecosystem fits a classic triangle of increasing concentrations of toxic compounds up the food chain. However, because BMAA is polar and nonlipophilic, a mechanism for its biomagnification through increasing trophic levels has been unclear. We report that BMAA occurs not only as a free amino acid in the Guam ecosystem but also can be released from a bound form by acid hydrolysis. After first removing free amino acids from tissue samples of various trophic levels (cyanobacteria, root symbioses, cycad seeds, cycad flour, flying foxes eaten by the Chamorro people, and brain tissues of Chamorros who died from amyotrophic lateral sclerosis/Parkinsonism dementia complex), we then hydrolyzed the remaining fraction and found BMAA concentrations increased 10- to 240-fold. This bound form of BMAA may function as an endogenous neurotoxic reservoir, accumulating and being transported between trophic levels and subsequently being released during digestion and protein metabolism. Within brain tissues, the endogenous neurotoxic reservoir can slowly release free BMAA, thereby causing incipient and recurrent neurological damage over years or even decades, which may explain the observed long latency period for neurological disease onset among the Chamorro people. The presence of BMAA in brain tissues from Canadian patients who died of Alzheimer's disease suggests that exposure to cyanobacterial neurotoxins occurs outside of Guam.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., & Robertson, R. C. (1987) · Science · doi:10.1126/science.3603037 · Cited by 897
Cox, P. A., Banack, S. A., & Murch, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235808100 · Cited by 633
Self-citationCyanobacterial toxins, exposure routes and human health
CODD, G. A., BELL, S. G., KAYA, K., WARD, C. J., BEATTIE, K. A., & METCALF, J. S. (1999) · European Journal of Phycology · doi:10.1017/s0967026299002255 · Cited by 565
Experimental and clinical neurotoxicology
(1982) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(82)80027-6 · Cited by 506
Motor Neurons Are Selectively Vulnerable to AMPA/Kainate Receptor-Mediated InjuryIn Vitro
Carriedo, S. G., Yin, H. Z., & Weiss, J. H. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04069.1996 · Cited by 441
Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam
Murch, S. J., Cox, P. A., Banack, S. A., Steele, J. C., & Sacks, O. W. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00320.x · Cited by 346
Self-citationCycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam
Cox, P. A., & Sacks, O. W. (2002) · Neurology · doi:10.1212/wnl.58.6.956 · Cited by 329
Self-citationCa2+–Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration
Weiss, J. H., & Sensi, S. L. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01610-6 · Cited by 255
Biomagnification of cycad neurotoxins in flying foxes: Implications for ALS-PDC in Guam
Banack, S. A., & Cox, P. A. (2003) · Neurology · doi:10.1212/01.wnl.0000078320.18564.9f · Cited by 244
Self-citationDuncan, M. W., Steele, J. C., Kopin, I. J., & Markey, S. P. (1990) · Neurology · doi:10.1212/wnl.40.5.767 · Cited by 192
Cited by
The rise of harmful cyanobacteria blooms: the potential roles of eutrophication and climate change
O’Neil, J. M., Davis, T. W., Burford, M. A., & Gobler, C. J. (2012) · Harmful Algae · doi:10.1016/j.hal.2011.10.027 · Cited by 2,225
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806
Diverse taxa of cyanobacteria produce β- N -methylamino- l -alanine, a neurotoxic amino acid
Cox, P. A., Banack, S. A., Murch, S. J., Rasmussen, U., Tien, G., Bidigare, R. R., Metcalf, J. S., Morrison, L. F., Codd, G. A., & Bergman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501526102 · Cited by 707
Self-citationHuman Health Risk Assessment Related to Cyanotoxins Exposure
Funari, E., & Testai, E. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440701749454 · Cited by 514
Corbel, S., Mougin, C., & Bouaïcha, N. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2013.07.056 · Cited by 343
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease
Pablo, J., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., & Mash, D. C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01150.x · Cited by 333
Self-citationDunlop, R. A., Cox, P. A., Banack, S. A., & Rodgers, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075376 · Cited by 314
Self-citationJonasson, S., Eriksson, J., Berntzon, L., Spáčil, Z., Ilag, L. L., Ronnevi, L.-O., Rasmussen, U., & Bergman, B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914417107 · Cited by 301
BMAA selectively injures motor neurons via AMPA/kainate receptor activation
Rao, S. D., Banack, S. A., Cox, P. A., & Weiss, J. H. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.017 · Cited by 279
Self-citationCox, P. A., Davis, D. A., Mash, D. C., Metcalf, J. S., & Banack, S. A. (2016) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2015.2397 · Cited by 256
Self-citationBrand, L. E., Pablo, J., Compton, A., Hammerschlag, N., & Mash, D. C. (2010) · Harmful Algae · doi:10.1016/j.hal.2010.05.002 · Cited by 256
β-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms
Lobner, D., Piana, P. M. T., Salous, A. K., & Peoples, R. W. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.002 · Cited by 255
Neurotoxic cyanobacterial toxins
Aráoz, R., Molgó, J., & Tandeau de Marsac, N. (2010) · Toxicon · doi:10.1016/j.toxicon.2009.07.036 · Cited by 252
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
Di Gioia, D., Bozzi Cionci, N., Baffoni, L., Amoruso, A., Pane, M., Mogna, L., Gaggìa, F., Lucenti, M. A., Bersano, E., Cantello, R., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01607-9 · Cited by 151
“demonstrated that BMAA is higher in human brains of patients with ALS/PDC with respect to controls [48].”
BackgroundStrategies to optimize the validity of disease models in the drug discovery process
Sams-Dodd, F. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.02.005 · Cited by 60
Castanedo-Vazquez, D., Bosque-Varela, P., Sainz-Pelayo, A., & Riancho, J. (2019) · Journal of Neurology · doi:10.1007/s00415-018-8919-3 · Cited by 41
Bradley, W. G., Miller, R. X., Levine, T. D., Stommel, E. W., & Cox, P. A. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9741-x · Cited by 28
Self-citationEnvironmental Protection Strategies: An Overview
Malik, A., Rahman, M., Ansari, M. I., Masood, F., & Grohmann, E. (2012) · Environmental Protection Strategies for Sustainable Development · doi:10.1007/978-94-007-1591-2_1 · Cited by 11
Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis
Bradley, W. G. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903285951 · Cited by 5
Metadata
- Authors
- Murch, S. J., Cox, P. A., & Banack, S. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-08-04
- Volume
- 101
- Issue
- 33
- Pages
- 12228-12231
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2025541331
- Cited by
- 416
- References
- 19
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.